These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 12738711)
1. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Segura-Pacheco B; Trejo-Becerril C; Perez-Cardenas E; Taja-Chayeb L; Mariscal I; Chavez A; Acuña C; Salazar AM; Lizano M; Dueñas-Gonzalez A Clin Cancer Res; 2003 May; 9(5):1596-603. PubMed ID: 12738711 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Bender CM; Pao MM; Jones PA Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064 [TBL] [Abstract][Full Text] [Related]
3. 5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells. Yang Q; Shan L; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K Anticancer Res; 2002; 22(5):2753-6. PubMed ID: 12529992 [TBL] [Abstract][Full Text] [Related]
4. A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. Zambrano P; Segura-Pacheco B; Perez-Cardenas E; Cetina L; Revilla-Vazquez A; Taja-Chayeb L; Chavez-Blanco A; Angeles E; Cabrera G; Sandoval K; Trejo-Becerril C; Chanona-Vilchis J; Duenas-González A BMC Cancer; 2005 Apr; 5():44. PubMed ID: 15862127 [TBL] [Abstract][Full Text] [Related]
5. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913 [TBL] [Abstract][Full Text] [Related]
6. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression. Song Y; Zhang C Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605 [TBL] [Abstract][Full Text] [Related]
7. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related]
8. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Chuang JC; Yoo CB; Kwan JM; Li TW; Liang G; Yang AS; Jones PA Mol Cancer Ther; 2005 Oct; 4(10):1515-20. PubMed ID: 16227400 [TBL] [Abstract][Full Text] [Related]
9. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315 [TBL] [Abstract][Full Text] [Related]
10. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of inhibition of DNA methylation of the retinoic acid receptor beta gene by 5-Aza-2'-deoxycytidine in tumor cells using a single-nucleotide primer extension assay. Bovenzi V; Momparler RL Anal Biochem; 2000 May; 281(1):55-61. PubMed ID: 10847610 [TBL] [Abstract][Full Text] [Related]
12. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. Bovenzi V; Momparler RL Cancer Chemother Pharmacol; 2001 Jul; 48(1):71-6. PubMed ID: 11488527 [TBL] [Abstract][Full Text] [Related]
13. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells. Primeau M; Gagnon J; Momparler RL Int J Cancer; 2003 Jan; 103(2):177-84. PubMed ID: 12455031 [TBL] [Abstract][Full Text] [Related]
14. The synergistic effect of 5-aza-2'-deoxycytidine and 5-fluorouracil on drug-resistant tumors. Morita S; Iida S; Kato K; Takagi Y; Uetake H; Sugihara K Oncology; 2006; 71(5-6):437-45. PubMed ID: 17690560 [TBL] [Abstract][Full Text] [Related]
15. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Ferguson AT; Lapidus RG; Baylin SB; Davidson NE Cancer Res; 1995 Jun; 55(11):2279-83. PubMed ID: 7538900 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine. Bovenzi V; Lê NL; Côte S; Sinnett D; Momparler LF; Momparler RL Anticancer Drugs; 1999 Jun; 10(5):471-6. PubMed ID: 10477167 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment. Egger G; Aparicio AM; Escobar SG; Jones PA Cancer Res; 2007 Jan; 67(1):346-53. PubMed ID: 17210717 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180 [TBL] [Abstract][Full Text] [Related]
19. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805 [TBL] [Abstract][Full Text] [Related]
20. Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]